Literature DB >> 27712873

Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer.

Dong-Dong Huang1, Chong-Jun Zhou2, Su-Lin Wang2, Shu-Ting Mao3, Xuan-You Zhou3, Neng Lou2, Zhao Zhang4, Zhen Yu5, Xian Shen2, Cheng-Le Zhuang6.   

Abstract

BACKGROUND: The association between sarcopenia and postoperative outcomes has been well reported. However, the impact of different sarcopenia stages on postoperative outcomes has never been investigated.
METHODS: We conducted a large, prospective study of patients who underwent radical gastrectomy for gastric cancer from August 2014 to December 2015. Sarcopenia was staged as "presarcopenia," "sarcopenia," and "severe sarcopenia" according to the definition of the European Working Group on Sarcopenia in Older People. Univariate and multivariate analyses evaluating the risk factors for total, surgical, and medical complications were performed.
RESULTS: A total of 470 patients were included, in which 20.6%, 10%, and 6.8% of the patients were identified as having "presarcopenia," "sarcopenia," and "severe sarcopenia," respectively. Postoperative complications, duration of hospital stays, and costs increased with advancing sarcopenia stages. Severe sarcopenia, visceral fat area to total abdominal muscle area ratio, American Society of Anesthesiologists grade III, and tumor located at the cardia were independent risk factors for total complications. Visceral fat area to total abdominal muscle area ratio and tumor located at the cardia were independent risk factors for operative complications. Presarcopenia, sarcopenia, and severe sarcopenia were all identified as independent risk factors for medical complications, as well as age ≥75 years and Charlson Comorbidity Index.
CONCLUSION: Patients had worse postoperative outcomes after gastric cancer operation with advancing sarcopenia stages. Severe sarcopenia, but not presarcopenia or sarcopenia, was an independent risk factor for total postoperative complications. The 3 sarcopenia stages independently influence medical but not surgical complications. Recognizing sarcopenia stages is important for preoperative risk stratification.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27712873     DOI: 10.1016/j.surg.2016.08.030

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  27 in total

Review 1.  Sarcopenia in gastric cancer: when the loss costs too much.

Authors:  Elena Ongaro; Vanessa Buoro; Marika Cinausero; Riccardo Caccialanza; Annalisa Turri; Valentina Fanotto; Debora Basile; Maria Grazia Vitale; Paola Ermacora; Giovanni Gerardo Cardellino; Laura Nicoletti; Lorenzo Fornaro; Andrea Casadei-Gardini; Giuseppe Aprile
Journal:  Gastric Cancer       Date:  2017-05-05       Impact factor: 7.370

2.  Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic Review.

Authors:  Zhengdao Yang; Xin Zhou; Bin Ma; Yanan Xing; Xue Jiang; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-07-09       Impact factor: 3.452

3.  Effect of Short-Term Preoperative Parenteral Nutrition Support for Gastric Cancer Patients with Sarcopenia: a Propensity Score Matching Analysis.

Authors:  Ze-Xin Huang; Hui-Hui Zhang; Wei-Teng Zhang; Ming-Ming Shi; Jia-Huan Ren; Li-Bin Xu; Xiao-Dong Chen; Guan-Bao Zhu
Journal:  J Gastrointest Surg       Date:  2022-01-29       Impact factor: 3.267

4.  Impact of Visceral Obesity and Sarcopenia on Short-Term Outcomes After Colorectal Cancer Surgery.

Authors:  Wei-Zhe Chen; Xiao-Dong Chen; Liang-Liang Ma; Feng-Min Zhang; Ji Lin; Cheng-Le Zhuang; Zhen Yu; Xiao-Lei Chen; Xiao-Xi Chen
Journal:  Dig Dis Sci       Date:  2018-03-16       Impact factor: 3.199

Review 5.  Disease-Related Malnutrition and Sarcopenia as Determinants of Clinical Outcome.

Authors:  Fatuma Meyer; Luzia Valentini
Journal:  Visc Med       Date:  2019-09-02

6.  Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric study.

Authors:  A A Ricciardolo; N De Ruvo; F Serra; F Prampolini; L Solaini; S Battisti; G Missori; S Fenocchi; E G Rossi; L Sorrentino; M Salati; A Spallanzani; N Cautero; A Pecchi; G Ercolani; R Gelmini
Journal:  Updates Surg       Date:  2021-10-26

7.  Sarcopenia may Influence the Prognosis in Advanced Thyroid Cancer Patients Treated With Molecular Targeted Therapy.

Authors:  Akihiro Nishiyama; Yukiko Staub; Yukio Suga; Mikiya Fujita; Azusa Tanimoto; Koushiro Ohtsubo; Seiji Yano
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

8.  Validation of Skeletal Muscle Volume as a Nutritional Assessment in Patients With Gastric or Colorectal Cancer Before Radical Surgery.

Authors:  Takayuki Endo; Chika Momoki; Minori Yamaoka; Saki Hachino; Satoshi Iwatani; Seiji Kiyota; Hiromu Tanaka; Daiki Habu
Journal:  J Clin Med Res       Date:  2017-09-01

9.  Association of Sarcopenia and Body Composition With Short-term Outcomes After Liver Resection for Malignant Tumors.

Authors:  Giammauro Berardi; Giulio Antonelli; Marco Colasanti; Roberto Meniconi; Nicola Guglielmo; Andrea Laurenzi; Stefano Ferretti; Giovanni Battista Levi Sandri; Alessandra Spagnoli; Giovanni Moschetta; Vincenzo Schininà; Mario Antonini; Massimo Marignani; Giuseppe Maria Ettorre
Journal:  JAMA Surg       Date:  2020-11-18       Impact factor: 14.766

10.  Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long-Term Survival in Gastric Cancer.

Authors:  Xiangwei Sun; Jianfeng Xu; Xiaodong Chen; Weiteng Zhang; Wenjing Chen; Ce Zhu; Jing Sun; Xinxin Yang; Xiang Wang; Yingying Hu; Yiqi Cai; Xian Shen
Journal:  Clin Transl Sci       Date:  2021-05-01       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.